Seven patients in group A became tumor free after recurrence following treatments combined with immunotherapy: two cases of EGFR-TKI, three cases of resection of lung metastasis, one case of ALK fusion gene inhibitor, and 1 of radiation; and continued to be tumor free until the time of the final analysis. The gene discussed is EGFR; the disease is neoplasm.